

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of cell killing (GO:0031342) | 5.92244938 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.92244938 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.03857128 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.03857128 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.03857128 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.03857128 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.03857128 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.03857128 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.86309611 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78993045 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.66705622 |
| 12 | response to peptidoglycan (GO:0032494) | 4.61816475 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.54774675 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44743731 |
| 15 | leukocyte aggregation (GO:0070486) | 4.38602667 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.25058993 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24960682 |
| 18 | detection of other organism (GO:0098543) | 4.17634951 |
| 19 | detection of bacterium (GO:0016045) | 4.03708672 |
| 20 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.97685930 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.95883784 |
| 22 | response to muramyl dipeptide (GO:0032495) | 3.84215774 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.80824491 |
| 24 | negative regulation of interleukin-12 production (GO:0032695) | 3.80169595 |
| 25 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.69075159 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66158275 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.55415807 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.53099914 |
| 29 | cellular extravasation (GO:0045123) | 3.47126944 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.44235182 |
| 31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.40267738 |
| 32 | germinal center formation (GO:0002467) | 3.38100626 |
| 33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.36871087 |
| 34 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33466374 |
| 35 | response to host immune response (GO:0052572) | 3.33466374 |
| 36 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30689243 |
| 37 | response to host (GO:0075136) | 3.30689243 |
| 38 | response to host defenses (GO:0052200) | 3.30689243 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 3.27779260 |
| 40 | response to interleukin-15 (GO:0070672) | 3.26474914 |
| 41 | neutrophil activation (GO:0042119) | 3.24197665 |
| 42 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.21312460 |
| 43 | negative regulation of T cell mediated immunity (GO:0002710) | 3.20346690 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 3.18904777 |
| 45 | detection of biotic stimulus (GO:0009595) | 3.14416407 |
| 46 | granulocyte activation (GO:0036230) | 3.09886733 |
| 47 | negative regulation of type 2 immune response (GO:0002829) | 3.09585941 |
| 48 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.06564532 |
| 49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.06535684 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03737811 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 3.03737473 |
| 52 | positive thymic T cell selection (GO:0045059) | 3.02823079 |
| 53 | regulation of T cell tolerance induction (GO:0002664) | 3.00390834 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 2.99966304 |
| 55 | tolerance induction (GO:0002507) | 2.99151382 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 2.98224974 |
| 57 | B cell receptor signaling pathway (GO:0050853) | 2.98124782 |
| 58 | respiratory burst (GO:0045730) | 2.97017717 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96939488 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 2.95689440 |
| 61 | type I interferon signaling pathway (GO:0060337) | 2.95546148 |
| 62 | cellular response to type I interferon (GO:0071357) | 2.95546148 |
| 63 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.95098533 |
| 64 | response to type I interferon (GO:0034340) | 2.93251577 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91737420 |
| 66 | macrophage activation (GO:0042116) | 2.91391766 |
| 67 | regulation of tolerance induction (GO:0002643) | 2.87778430 |
| 68 | T cell homeostasis (GO:0043029) | 2.87289234 |
| 69 | negative regulation of interleukin-6 production (GO:0032715) | 2.86994943 |
| 70 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86364318 |
| 71 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.85501876 |
| 72 | response to laminar fluid shear stress (GO:0034616) | 2.84017017 |
| 73 | negative regulation of innate immune response (GO:0045824) | 2.82117507 |
| 74 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80002032 |
| 75 | negative thymic T cell selection (GO:0045060) | 2.79755733 |
| 76 | signal complex assembly (GO:0007172) | 2.77163746 |
| 77 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77091894 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76846066 |
| 79 | thymic T cell selection (GO:0045061) | 2.75326518 |
| 80 | positive regulation of B cell differentiation (GO:0045579) | 2.74971901 |
| 81 | T cell migration (GO:0072678) | 2.74256788 |
| 82 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.73764800 |
| 83 | regulation of type 2 immune response (GO:0002828) | 2.72976730 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.71921441 |
| 85 | negative T cell selection (GO:0043383) | 2.69568745 |
| 86 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.69561184 |
| 87 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.69561184 |
| 88 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.67497237 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.67497237 |
| 90 | regulation of B cell differentiation (GO:0045577) | 2.66529854 |
| 91 | T cell selection (GO:0045058) | 2.66060362 |
| 92 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62800874 |
| 93 | protein localization to endosome (GO:0036010) | 2.62372749 |
| 94 | microglial cell activation (GO:0001774) | 2.61911192 |
| 95 | defense response to protozoan (GO:0042832) | 2.60074565 |
| 96 | neutrophil mediated immunity (GO:0002446) | 2.59849572 |
| 97 | B cell homeostasis (GO:0001782) | 2.59760203 |
| 98 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57263807 |
| 99 | regulation of platelet aggregation (GO:0090330) | 2.56868895 |
| 100 | positive regulation of tolerance induction (GO:0002645) | 2.56496543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.26257115 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.91791093 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.87666001 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.85676942 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 2.82432718 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.76683254 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.61285978 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.60410296 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.52738856 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.51686536 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48882777 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.45998926 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45234203 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.44858675 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.44232534 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40711302 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.38466300 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.38128375 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.36462185 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.36160739 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32011374 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27997068 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.27818058 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25733646 |
| 25 | UTX_26944678_Chip-Seq_JUKART_Human | 2.10539689 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.08915711 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.06229273 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01613420 |
| 29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.99531240 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96327484 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94910774 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94849886 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90660663 |
| 34 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88951505 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85386218 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84935134 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.84860274 |
| 38 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.83313695 |
| 39 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.78713312 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78126645 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.76091541 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73238369 |
| 43 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.72174033 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.71608097 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.66883305 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63400960 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61496709 |
| 48 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52482460 |
| 49 | MYB_26560356_Chip-Seq_TH2_Human | 1.50570542 |
| 50 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47354875 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46283851 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.43898413 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.43515381 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.41992377 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37799545 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33793751 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.32690440 |
| 58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.31975417 |
| 59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31745519 |
| 60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31704191 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28957236 |
| 62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26756469 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25610614 |
| 64 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24179984 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21513926 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20790518 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20616466 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19863338 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18170547 |
| 70 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.17978289 |
| 71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17184134 |
| 72 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16478158 |
| 73 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14587586 |
| 74 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14461058 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14024705 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12559798 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11037599 |
| 78 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10465211 |
| 79 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.08889123 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07892705 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07525088 |
| 82 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06255629 |
| 83 | P68_20966046_ChIP-Seq_HELA_Human | 1.04894008 |
| 84 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04557939 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04542774 |
| 86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04212667 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03581394 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.02864211 |
| 89 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02863588 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02052227 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01853445 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.99162604 |
| 93 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97569799 |
| 94 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96454040 |
| 95 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96408869 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.95017667 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92112704 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91528593 |
| 99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90540217 |
| 100 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.90021815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.15498565 |
| 2 | MP0003303_peritoneal_inflammation | 3.78742369 |
| 3 | MP0003724_increased_susceptibility_to | 3.59565862 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.98495003 |
| 5 | MP0005451_abnormal_body_composition | 2.81141704 |
| 6 | MP0000685_abnormal_immune_system | 2.79874654 |
| 7 | MP0002419_abnormal_innate_immunity | 2.79486549 |
| 8 | MP0005025_abnormal_response_to | 2.63811088 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.63626123 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.62264056 |
| 11 | MP0005387_immune_system_phenotype | 2.62068858 |
| 12 | MP0001790_abnormal_immune_system | 2.62068858 |
| 13 | MP0001800_abnormal_humoral_immune | 2.55104082 |
| 14 | MP0005671_abnormal_response_to | 2.53457503 |
| 15 | MP0009785_altered_susceptibility_to | 2.40930197 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.40478480 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.33865391 |
| 18 | MP0002723_abnormal_immune_serum | 2.33757487 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.30764246 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.28969483 |
| 21 | MP0001819_abnormal_immune_cell | 2.25636427 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.25320615 |
| 23 | MP0004947_skin_inflammation | 2.24287846 |
| 24 | MP0006082_CNS_inflammation | 2.22817185 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.10376866 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.01991854 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.99325152 |
| 28 | MP0002405_respiratory_system_inflammati | 1.98158584 |
| 29 | MP0003828_pulmonary_edema | 1.95348464 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.93113702 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.85597973 |
| 32 | MP0009278_abnormal_bone_marrow | 1.79141300 |
| 33 | MP0002398_abnormal_bone_marrow | 1.77975774 |
| 34 | MP0000716_abnormal_immune_system | 1.75409675 |
| 35 | MP0004510_myositis | 1.72095293 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.61711669 |
| 37 | MP0002998_abnormal_bone_remodeling | 1.57875882 |
| 38 | MP0000858_altered_metastatic_potential | 1.56754106 |
| 39 | MP0008260_abnormal_autophagy | 1.53985707 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.53957164 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.51309376 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.47380832 |
| 43 | MP0003091_abnormal_cell_migration | 1.45915590 |
| 44 | MP0002722_abnormal_immune_system | 1.42489243 |
| 45 | MP0002429_abnormal_blood_cell | 1.37558930 |
| 46 | MP0003075_altered_response_to | 1.36984166 |
| 47 | MP0002132_abnormal_respiratory_system | 1.34340023 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.34222081 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.34042787 |
| 50 | MP0001851_eye_inflammation | 1.28264502 |
| 51 | MP0008004_abnormal_stomach_pH | 1.26717296 |
| 52 | MP0004381_abnormal_hair_follicle | 1.26130740 |
| 53 | MP0008469_abnormal_protein_level | 1.25767505 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.24900885 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.22701298 |
| 56 | MP0001873_stomach_inflammation | 1.19257165 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.19246156 |
| 58 | MP0009840_abnormal_foam_cell | 1.17588240 |
| 59 | MP0003279_aneurysm | 1.14174487 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.13128285 |
| 61 | MP0003448_altered_tumor_morphology | 1.13103546 |
| 62 | MP0004883_abnormal_blood_vessel | 1.13030743 |
| 63 | MP0005310_abnormal_salivary_gland | 1.13014577 |
| 64 | MP0001849_ear_inflammation | 1.12092091 |
| 65 | MP0003866_abnormal_defecation | 1.12055919 |
| 66 | MP0009764_decreased_sensitivity_to | 1.08636792 |
| 67 | MP0001853_heart_inflammation | 1.08523814 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.06778425 |
| 69 | MP0005166_decreased_susceptibility_to | 1.04199640 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.03114469 |
| 71 | MP0001545_abnormal_hematopoietic_system | 1.03114469 |
| 72 | MP0004808_abnormal_hematopoietic_stem | 0.98669272 |
| 73 | MP0005390_skeleton_phenotype | 0.96356833 |
| 74 | MP0001348_abnormal_lacrimal_gland | 0.96090859 |
| 75 | MP0002933_joint_inflammation | 0.95774000 |
| 76 | MP0004130_abnormal_muscle_cell | 0.93969090 |
| 77 | MP0000604_amyloidosis | 0.93466893 |
| 78 | MP0004858_abnormal_nervous_system | 0.92896147 |
| 79 | MP0003690_abnormal_glial_cell | 0.92885178 |
| 80 | MP0005164_abnormal_response_to | 0.91219381 |
| 81 | MP0000343_altered_response_to | 0.91193967 |
| 82 | MP0005023_abnormal_wound_healing | 0.84808706 |
| 83 | MP0001958_emphysema | 0.83429117 |
| 84 | MP0000490_abnormal_crypts_of | 0.80729667 |
| 85 | MP0004185_abnormal_adipocyte_glucose | 0.80729237 |
| 86 | MP0000767_abnormal_smooth_muscle | 0.78648543 |
| 87 | MP0002166_altered_tumor_susceptibility | 0.77785139 |
| 88 | MP0001663_abnormal_digestive_system | 0.77722660 |
| 89 | MP0008874_decreased_physiological_sensi | 0.77533529 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.74864659 |
| 91 | MP0003795_abnormal_bone_structure | 0.71544246 |
| 92 | MP0000733_abnormal_muscle_development | 0.71075812 |
| 93 | MP0001915_intracranial_hemorrhage | 0.69126704 |
| 94 | MP0000678_abnormal_parathyroid_gland | 0.67360941 |
| 95 | MP0003329_amyloid_beta_deposits | 0.67130406 |
| 96 | MP0000249_abnormal_blood_vessel | 0.65641472 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.64260413 |
| 98 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62110603 |
| 99 | MP0009763_increased_sensitivity_to | 0.59941832 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 0.55994344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.49450040 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.93307878 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.82171149 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.63609616 |
| 5 | Myositis (HP:0100614) | 4.12743214 |
| 6 | Orchitis (HP:0100796) | 3.94851591 |
| 7 | Increased IgE level (HP:0003212) | 3.78671481 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.49821380 |
| 9 | Optic neuritis (HP:0100653) | 3.49821380 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.35833102 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.27453377 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.26199129 |
| 13 | Meningitis (HP:0001287) | 3.19914581 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.19573689 |
| 15 | Recurrent skin infections (HP:0001581) | 3.16372428 |
| 16 | Cellulitis (HP:0100658) | 3.14208034 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.14151323 |
| 18 | Pustule (HP:0200039) | 3.01858418 |
| 19 | Obstructive lung disease (HP:0006536) | 2.99207260 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 2.99207260 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 2.87906990 |
| 22 | Stomatitis (HP:0010280) | 2.86773226 |
| 23 | Gingivitis (HP:0000230) | 2.85681799 |
| 24 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84179155 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 2.73982972 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.73982972 |
| 27 | Urticaria (HP:0001025) | 2.73648306 |
| 28 | Vasculitis (HP:0002633) | 2.63462192 |
| 29 | Keratoconjunctivitis sicca (HP:0001097) | 2.56380431 |
| 30 | Recurrent viral infections (HP:0004429) | 2.51652391 |
| 31 | Encephalitis (HP:0002383) | 2.47985884 |
| 32 | Peritonitis (HP:0002586) | 2.46282523 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.34788456 |
| 34 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.33582882 |
| 35 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.33582882 |
| 36 | Abnormality of glycolipid metabolism (HP:0010969) | 2.33582882 |
| 37 | Hypochromic anemia (HP:0001931) | 2.32936163 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.32648893 |
| 39 | Chest pain (HP:0100749) | 2.31680238 |
| 40 | Inflammation of the large intestine (HP:0002037) | 2.30465476 |
| 41 | Prolonged bleeding time (HP:0003010) | 2.27734958 |
| 42 | T lymphocytopenia (HP:0005403) | 2.26937483 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.18710520 |
| 44 | Axonal loss (HP:0003447) | 2.15900477 |
| 45 | Colitis (HP:0002583) | 2.13488997 |
| 46 | Loss of speech (HP:0002371) | 2.12320797 |
| 47 | Slow saccadic eye movements (HP:0000514) | 2.10790511 |
| 48 | Obstructive sleep apnea (HP:0002870) | 2.09880626 |
| 49 | Abnormality of T cell number (HP:0011839) | 2.09616641 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.09156454 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.07901438 |
| 52 | Leukocytosis (HP:0001974) | 2.07532170 |
| 53 | Hemoptysis (HP:0002105) | 2.07203504 |
| 54 | Hypergammaglobulinemia (HP:0010702) | 2.04483888 |
| 55 | Nasal polyposis (HP:0100582) | 2.04388973 |
| 56 | Epistaxis (HP:0000421) | 2.03103685 |
| 57 | Sepsis (HP:0100806) | 2.02282634 |
| 58 | Osteomyelitis (HP:0002754) | 2.01843714 |
| 59 | Gingival bleeding (HP:0000225) | 1.99889812 |
| 60 | Difficulty running (HP:0009046) | 1.98559381 |
| 61 | Emphysema (HP:0002097) | 1.96897796 |
| 62 | Hyperacusis (HP:0010780) | 1.95734698 |
| 63 | Episodic fever (HP:0001954) | 1.95319190 |
| 64 | Arterial thrombosis (HP:0004420) | 1.94888516 |
| 65 | Pulmonary embolism (HP:0002204) | 1.92823945 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 1.92749318 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.92425716 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 1.91436799 |
| 69 | Gastrointestinal stroma tumor (HP:0100723) | 1.90352574 |
| 70 | Abnormality of the peritoneum (HP:0002585) | 1.89299887 |
| 71 | Increased IgM level (HP:0003496) | 1.88564903 |
| 72 | Spondylolisthesis (HP:0003302) | 1.88296466 |
| 73 | Granulocytopenia (HP:0001913) | 1.87068606 |
| 74 | Increased serum ferritin (HP:0003281) | 1.86312236 |
| 75 | Interstitial pulmonary disease (HP:0006530) | 1.85204056 |
| 76 | Amyloidosis (HP:0011034) | 1.85057074 |
| 77 | Dysostosis multiplex (HP:0000943) | 1.84769578 |
| 78 | Supranuclear gaze palsy (HP:0000605) | 1.84120447 |
| 79 | Petechiae (HP:0000967) | 1.83997360 |
| 80 | Increased connective tissue (HP:0009025) | 1.83701773 |
| 81 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83698742 |
| 82 | Agammaglobulinemia (HP:0004432) | 1.83528828 |
| 83 | Premature loss of primary teeth (HP:0006323) | 1.82489317 |
| 84 | Purpura (HP:0000979) | 1.82200575 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 1.81551617 |
| 86 | Lymphopenia (HP:0001888) | 1.81146276 |
| 87 | Dilatation of the ascending aorta (HP:0005111) | 1.79008647 |
| 88 | Papilloma (HP:0012740) | 1.76816928 |
| 89 | Verrucae (HP:0200043) | 1.76816928 |
| 90 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76491481 |
| 91 | Muscle fiber splitting (HP:0003555) | 1.75180889 |
| 92 | Microcytic anemia (HP:0001935) | 1.74992111 |
| 93 | Cerebral aneurysm (HP:0004944) | 1.74917815 |
| 94 | Thin bony cortex (HP:0002753) | 1.73735216 |
| 95 | Abnormality of the endocardium (HP:0004306) | 1.73603717 |
| 96 | Abnormality of the fingertips (HP:0001211) | 1.73535525 |
| 97 | Broad face (HP:0000283) | 1.72543617 |
| 98 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.72173136 |
| 99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.70836210 |
| 100 | Viral hepatitis (HP:0006562) | 1.70792270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.42580753 |
| 2 | RIPK4 | 3.17248956 |
| 3 | ERN1 | 3.01796865 |
| 4 | MAP4K1 | 2.86821574 |
| 5 | TRIB3 | 2.59726757 |
| 6 | MAP2K3 | 2.59547560 |
| 7 | IRAK4 | 2.28262931 |
| 8 | CSK | 2.16335222 |
| 9 | FES | 2.06936009 |
| 10 | EPHB1 | 2.01543577 |
| 11 | TYK2 | 1.97470958 |
| 12 | TNK2 | 1.93717683 |
| 13 | SIK1 | 1.87695435 |
| 14 | MAP3K11 | 1.85833323 |
| 15 | BLK | 1.85155377 |
| 16 | TAOK1 | 1.84444116 |
| 17 | MAP3K3 | 1.80954780 |
| 18 | SIK2 | 1.80599418 |
| 19 | SMG1 | 1.76951754 |
| 20 | ZAP70 | 1.72801761 |
| 21 | SIK3 | 1.72277857 |
| 22 | ICK | 1.71618946 |
| 23 | MAP3K14 | 1.55332812 |
| 24 | MARK2 | 1.48970239 |
| 25 | PRKD2 | 1.47514309 |
| 26 | IRAK2 | 1.45386706 |
| 27 | TAOK2 | 1.42021853 |
| 28 | GRK6 | 1.40482160 |
| 29 | IKBKE | 1.40359550 |
| 30 | TBK1 | 1.40214753 |
| 31 | MAP3K13 | 1.38323994 |
| 32 | MAP3K1 | 1.36658113 |
| 33 | IRAK3 | 1.36186390 |
| 34 | BTK | 1.35571677 |
| 35 | KSR2 | 1.33817584 |
| 36 | HCK | 1.26815958 |
| 37 | FGR | 1.25258517 |
| 38 | JAK3 | 1.20405686 |
| 39 | TTN | 1.14476869 |
| 40 | CDC42BPA | 1.10355549 |
| 41 | SYK | 1.08548245 |
| 42 | RIPK1 | 1.06482529 |
| 43 | HIPK2 | 1.04802758 |
| 44 | DYRK1B | 1.03900566 |
| 45 | MAP3K10 | 1.03838988 |
| 46 | TXK | 1.03253884 |
| 47 | JAK1 | 1.02041048 |
| 48 | MAP3K6 | 0.96433060 |
| 49 | CDK12 | 0.91732831 |
| 50 | JAK2 | 0.88577505 |
| 51 | LRRK2 | 0.84366581 |
| 52 | MAPK12 | 0.84202785 |
| 53 | LCK | 0.83830093 |
| 54 | PTK6 | 0.83563131 |
| 55 | LYN | 0.82783939 |
| 56 | STK10 | 0.82389944 |
| 57 | CSF1R | 0.81750523 |
| 58 | FGFR4 | 0.80241912 |
| 59 | TGFBR2 | 0.79490152 |
| 60 | TYRO3 | 0.77425704 |
| 61 | MAP3K7 | 0.77096419 |
| 62 | DYRK3 | 0.77082413 |
| 63 | PDPK1 | 0.74082346 |
| 64 | SGK3 | 0.72003301 |
| 65 | MAP3K2 | 0.69957458 |
| 66 | MATK | 0.69819077 |
| 67 | IKBKB | 0.68242264 |
| 68 | RPS6KA2 | 0.67717776 |
| 69 | ITK | 0.67280921 |
| 70 | PDK1 | 0.66820131 |
| 71 | MAPK7 | 0.66394896 |
| 72 | TESK2 | 0.65541710 |
| 73 | RPS6KC1 | 0.63183051 |
| 74 | RPS6KL1 | 0.63183051 |
| 75 | IRAK1 | 0.60168806 |
| 76 | MARK3 | 0.59755904 |
| 77 | CDK19 | 0.57181502 |
| 78 | FYN | 0.55538266 |
| 79 | YES1 | 0.54223329 |
| 80 | PKN2 | 0.52822854 |
| 81 | MOS | 0.52140929 |
| 82 | NME2 | 0.51137238 |
| 83 | CAMKK1 | 0.49842792 |
| 84 | MELK | 0.48815996 |
| 85 | EEF2K | 0.48621369 |
| 86 | PRKCH | 0.46656456 |
| 87 | KIT | 0.45262073 |
| 88 | RPS6KA6 | 0.44612474 |
| 89 | RET | 0.44490178 |
| 90 | MAPKAPK2 | 0.43998498 |
| 91 | STK38 | 0.43003023 |
| 92 | STK11 | 0.42327541 |
| 93 | PDGFRB | 0.40892535 |
| 94 | FGFR3 | 0.39125300 |
| 95 | MAP3K8 | 0.38789267 |
| 96 | PAK4 | 0.38614724 |
| 97 | MTOR | 0.38488399 |
| 98 | CHUK | 0.38017248 |
| 99 | MAPK4 | 0.36753806 |
| 100 | CAMK4 | 0.36537724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63487894 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.25315941 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.18793478 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95152087 |
| 5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.94736865 |
| 6 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.91991175 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90735595 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84536362 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 1.72821955 |
| 10 | Malaria_Homo sapiens_hsa05144 | 1.70767317 |
| 11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.65840653 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65781582 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.65763629 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.65264048 |
| 15 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.58527939 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57485534 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56800716 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.54970722 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.53906553 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.49628950 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.48686773 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48362809 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.46894819 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44981448 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43928181 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.42259609 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39689473 |
| 28 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38017327 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.37816273 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35157006 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.33818380 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.33660098 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.33124554 |
| 34 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.30191855 |
| 35 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27703830 |
| 36 | Viral myocarditis_Homo sapiens_hsa05416 | 1.27210818 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.25011867 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.23884078 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23338321 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16880803 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16289686 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.15124125 |
| 43 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11632961 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09333107 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.09137910 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.08029345 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.06860652 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.05138291 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.05056219 |
| 50 | Phagosome_Homo sapiens_hsa04145 | 1.03247655 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02480703 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 1.01977980 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00442683 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.99416056 |
| 55 | Pertussis_Homo sapiens_hsa05133 | 0.98213014 |
| 56 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97797394 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95561571 |
| 58 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94456493 |
| 59 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.91962611 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.90914479 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86722551 |
| 62 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86341651 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86131925 |
| 64 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.85585295 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85428761 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.85158703 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85064100 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.80982572 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.80600226 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79335472 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76629046 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76418402 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73176181 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72790583 |
| 75 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72552432 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.71574514 |
| 77 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71340903 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71196295 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71088976 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.70528622 |
| 81 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68961091 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68946059 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.68826476 |
| 84 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67006728 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65675832 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.65447964 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.63961092 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62186113 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61586554 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61491524 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61198444 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59578691 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59555520 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59350624 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58463118 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57911511 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57666551 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56682935 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55627694 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54746690 |

